OZMOSI, a leading provider of structured pharmaceutical development intelligence, announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD). This integration brings external clinical reality into internal R&a…
Andelyn Biosciences, a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization ("CDMO"), and ENCell Co., Ltd, a Korea-based advanced biopharmaceutical CDMO, announced the signing of a Collaboration Agreement to establish a strategic manufacturing bridge between the United …
UCB (Euronext Brussels: UCB), a global biopharmaceutical company, announced that it has entered into a definitive agreement under which UCB would acquire Neurona Therapeutics, including lead asset NRTX-1001, adding to UCB's epilepsy portfolio. Neurona Therapeutics is a clinical-stage biotherapeutics company focused on…
Eli Lilly and Company and Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today announced a definitive agreement for Lilly to acquire Kelonia. Kelonia has developed a proprietary in vivo gene placement system (iGPS® ) that uses specially engineered lentiviral-based…
Medtronic plc, a global leader in healthcare technology, announced it has completed its acquisition of CathWorks, a privately held medical device company, which aims to transform how coronary artery disease (CAD) is diagnosed and treated. The acquisition follows a 2022 strategic partnership with a co-promotion agreeme…
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd, and Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical manufacturing services and platform technologies, have announced a strategic collaboration. Under this collab…
Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, announced the acquisition of Conexus Solutions, a premier life sciences technology and managed services partner specializing in CRM transformation across the Veeva and Salesforce ecosystems. With this acquisition, Axtria…
Apotex Corp. announced that it has secured a strategic sterile filling partnership with Halo Pharmaceuticals through an investment that provides Apotex with access to a significant portion of the overall sterile injectable filling capacity currently being installed and qualified at Halo's Whippany, New Jersey facility…
Telix and Regeneron Pharmaceuticals, Inc. announce a collaboration to jointly develop and commercialize next generation radiopharmaceutical therapies. The collaboration combines Telix’s radiopharmaceutical development platform, global manufacturing capabilities and supply chain infrastructure with Regene…
Haisco Pharmaceutical Group Co., Ltd. announced that it has entered into an exclusive licensing agreement with AbbVie, a global biopharmaceutical company. Under the agreement, Haisco grants AbbVie the exclusive rights to develop, manufacture, and commercialize novel medicines for the treatment of pain globally, exclud…
Page 13 of 39